Chemicals

5-Bromoquinazolin-6-ylthiourea

We are 5-Bromoquinazolin-6-ylthiourea CAS:842138-74-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Bromoquinazolin-6-ylthiourea

CAS.NO:842138-74-3

Synonyms:5-Bromoquinazolin-6-ylthiourea

N-(5-BroMo-6-quinoxalinyl)thiourea

(5-BroMo-6-quinoxalinyl)thiourea

N-(5-BROMOQUINOXALIN-6-YL)THIOUREA

5-Bromoquinaxolin-6-ylthiourea

Thiourea,N-(5-broMo-6-quinoxalinyl)

Physical and Chemical Properties:

Density 1.8±0.1 g/cm3

Boiling Point 435.4±55.0 °C at 760 mmHg

Melting Point 198-202ºC

Molecular Formula C9H7BrN4S

Molecular Weight 283.148

Flash Point 217.1±31.5 °C

Vapour Pressure 0.0±1.0 mmHg at 25°C

Index of Refraction 1.841

Specification:

Appearance:Light yellow to brown powder

Assay:≥98.0%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Brimonidine(CAS:59803-98-4) and Brimonidine tartrate(CAS:70359-46-5).

5-Bromoquinazolin-6-ylthiourea

Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.5-bromo-3-nitro-2-piridinol CAS:15862-34-7 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.1214369-42-2 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.1-cloro-8-fluorooctano CAS:593-14-6 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.

Product Name
6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid	View Details
5-Bromo-2-methoxypyridine Cas:13472-85-0	View Details
Bis(2-methoxyethyl)aminosulfur Trifluoride Cas:202289-38-1	View Details